Search for:

Search

Rubius Therapeutics

About Us
Our Science
Our Pipeline
Investors and Media
Contact

Menu Search

Induction of Antigen-Specific Immune Tolerance in Type 1 Diabetes by Antigen-Expressing Red Cell Therapeutics

Contact Us

399 Binney Street, Suite 300
Cambridge, MA 02139 617-679-9600

Home
About Us
Our Science
Our Pipeline
Investors and Media
Sitemap
Terms of Use
Privacy Policy

© Rubius Therapeutics, Inc. 2023 All Rights Reserved. RUBIUS and RED PLATFORM are registered trademarks of Rubius Therapeutics, Inc. RUBIUS THERAPEUTICS, RED CELL THERAPEUTICS and RCT are trademarks of Rubius Therapeutics, Inc. All other trademarks referenced herein are the properties of their respective owners.